Drugmakers Will Ask US Government to Pause Drug Price Negotiations, Bloomberg News Reports
Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday, citing Eli […]
NYSE: LLY
US FDA Revokes Authorization for Four COVID Antibody Drugs
The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from
US FDA Revokes Authorization for Four COVID Antibody Drugs Read More »
Lilly’s Weight-Loss Drug Zepbound Wins US FDA Approval for Sleep Apnea
On Friday, the U.S. Food and Drug Administration approved Eli Lilly’s (NYSE: LLY) weight-loss treatment, Zepbound, for obstructive sleep apnea,
Lilly’s Weight-Loss Drug Zepbound Wins US FDA Approval for Sleep Apnea Read More »
In Weight Loss Battle, Novo and Lilly Face Growing Offensive from Licensed Copies
SHANGHAI – As Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) expand sales of their popular diabetes and weight-loss
In Weight Loss Battle, Novo and Lilly Face Growing Offensive from Licensed Copies Read More »
Lilly’s Mounjaro Gains Market Share Over Wegovy in UK’s Private Obesity Drug Market
LONDON – Britons paying privately for obesity drugs are increasingly choosing Eli Lilly’s (NYSE: LLY) Mounjaro over Novo Nordisk’s (NYSE:
Lilly’s Mounjaro Gains Market Share Over Wegovy in UK’s Private Obesity Drug Market Read More »
Trump, RFK Jr. Met with Pfizer, Lilly Executives: Report
President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY) as
Trump, RFK Jr. Met with Pfizer, Lilly Executives: Report Read More »
Novo, Lilly Shares Rise as Biden Proposes Obesity Care Coverage
COPENHAGEN – Shares of weight-loss drug makers Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) rose on Tuesday after
Novo, Lilly Shares Rise as Biden Proposes Obesity Care Coverage Read More »
Americans Seeking Weight-Loss Drugs Face Supply and Insurance Hurdles
Americans are still eagerly seeking prescriptions for Eli Lilly’s (NYSE: LLY) and Novo Nordisk’s (NYSE: NVO) weight-loss and diabetes drugs
Americans Seeking Weight-Loss Drugs Face Supply and Insurance Hurdles Read More »
US Medicaid Programs Say Cost a Key Factor for Weight-Loss Drug Coverage, Survey Finds
NEW YORK – Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk (NYSE: NVO) and
US Medicaid Programs Say Cost a Key Factor for Weight-Loss Drug Coverage, Survey Finds Read More »
Britain to Study Use of Lilly’s Weight Loss Drug to Get People Back to Work
LONDON – Britain will study whether the use of Eli Lilly’s (NYSE: LLY) weight loss drug can get people back
Britain to Study Use of Lilly’s Weight Loss Drug to Get People Back to Work Read More »
Compounding Group Sues FDA Over Removal of Lilly’s Weight Loss Drug from Shortage List
On Monday, a drug compounding industry group sued the U.S. Food and Drug Administration over its decision to take Eli
Compounding Group Sues FDA Over Removal of Lilly’s Weight Loss Drug from Shortage List Read More »
Eli Lilly (NYSE: LLY) Invests $1.8 Billion to Expand Production of Key Drugs in Ireland
Eli Lilly (NYSE: LLY) is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely
Eli Lilly (NYSE: LLY) Invests $1.8 Billion to Expand Production of Key Drugs in Ireland Read More »
Weight-Loss Market to See 16 New Drugs by 2029: Report
The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business
Weight-Loss Market to See 16 New Drugs by 2029: Report Read More »
Eli Lilly (NYSE: LLY) Introduces Vials of Weight-Loss Drug Zepbound Starting at $399 Per Month
On Tuesday, Eli Lilly (NYSE: LLY) said it has begun selling vials of the lowest starter dose of its popular
NHS Likely to Block Eli Lilly (NYSE: LLY) Alzheimer’s Treatment, The Telegraph Reports
Eli Lilly’s (NYSE: LLY) treatment for early Alzheimer’s is expected to be blocked for use by Britain’s National Health Service
NHS Likely to Block Eli Lilly (NYSE: LLY) Alzheimer’s Treatment, The Telegraph Reports Read More »
Doctors Face Hurdles in Securing Wegovy for Older Americans with Heart Disease
NEW YORK – Older Americans are having little success getting prescriptions for the weight-loss drug Wegovy covered by Medicare despite
Doctors Face Hurdles in Securing Wegovy for Older Americans with Heart Disease Read More »
Roche to Fast-track Anti-Obesity Drug Development to Compete with Rivals: FT Report
Swiss drugmaker Roche plans to accelerate the development of its anti-obesity drugs to challenge rivals like Eli Lilly (NYSE: LLY)
Roche to Fast-track Anti-Obesity Drug Development to Compete with Rivals: FT Report Read More »
Eli Lilly (NYSE: LLY) Secures FDA Approval for Alzheimer’s Drug
On Tuesday, the U.S. Food and Drug Administration approved Eli Lilly’s (NYSE: LLY) treatment for early Alzheimer’s, making it the
Eli Lilly (NYSE: LLY) Secures FDA Approval for Alzheimer’s Drug Read More »
Eli Lilly and Company (LLY) to Purchase DICE Therapeutics (DICE) for $2.4 Billion
Eli Lilly and Company (NYSE: LLY) has reached an agreement to buy DICE Therapeutics, Inc. (NASDAQ: DICE). Eli Lilly will
Eli Lilly and Company (LLY) to Purchase DICE Therapeutics (DICE) for $2.4 Billion Read More »
